Published in J Cardiothorac Surg on January 18, 2010
The challenge to verify ceramide's role of apoptosis induction in human cardiomyocytes--a pilot study. J Cardiothorac Surg (2011) 0.80
Yama/CPP32 beta, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase. Cell (1995) 9.22
Measurement of cytosolic free Ca2+ in individual small cells using fluorescence microscopy with dual excitation wavelengths. Cell Calcium (1985) 3.23
Signal transducer and activator of transcription 3 is required for myocardial capillary growth, control of interstitial matrix deposition, and heart protection from ischemic injury. Circ Res (2004) 2.45
Targeted inhibition of p38 mitogen-activated protein kinase antagonizes cardiac injury and cell death following ischemia-reperfusion in vivo. J Biol Chem (2004) 2.24
Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors. Proc Natl Acad Sci U S A (2004) 2.11
Activation and caspase-mediated inhibition of PARP: a molecular switch between fibroblast necrosis and apoptosis in death receptor signaling. Mol Biol Cell (2002) 2.05
Protein kinase Cdelta activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria. J Biol Chem (2004) 1.62
Differences between outward currents of human atrial and subepicardial ventricular myocytes. J Physiol (1996) 1.50
Modulation of leukocyte-endothelial interactions by reactive metabolites of oxygen and nitrogen: relevance to ischemic heart disease. Free Radic Biol Med (1998) 1.19
Caspase inhibition protects against reovirus-induced myocardial injury in vitro and in vivo. J Virol (2004) 1.18
Role of nitric oxide in Ca2+ sensitivity of the slowly activating delayed rectifier K+ current in cardiac myocytes. Circ Res (2004) 1.15
Palmitate-induced apoptosis in neonatal cardiomyocytes is not dependent on the generation of ROS. Am J Physiol Heart Circ Physiol (2002) 1.10
Importance of antioxidant and antiapoptotic effects of beta-receptor blockers in heart failure therapy. Am J Physiol Heart Circ Physiol (2004) 1.00
Ca2+ dysregulation induces mitochondrial depolarization and apoptosis: role of Na+/Ca2+ exchanger and AKT. J Biol Chem (2005) 1.00
A synopsis of research in cardiac apoptosis and its application to congestive heart failure. Tex Heart Inst J (2007) 0.94
Cardioplegic arrest induces apoptosis signal-pathway in myocardial endothelial cells and cardiac myocytes. Eur J Cardiothorac Surg (2003) 0.93
Endothelial apoptosis is induced by serum of patients after cardiopulmonary bypass. Eur J Cardiothorac Surg (2000) 0.91
Pleiotropic effects of the beta-adrenoceptor blocker carvedilol on calcium regulation during oxidative stress-induced apoptosis in cardiomyocytes. J Pharmacol Exp Ther (2006) 0.89
Stimulation of cardiac apoptosis in essential hypertension: potential role of angiotensin II. Hypertension (2002) 0.89
Determination of histopathologic risk factors for postoperative atrial fibrillation in cardiac surgery. Ann Thorac Surg (2005) 0.87
Differential effects of amrinone and milrinone upon myocardial inflammatory signaling. Circulation (2002) 0.87
Cardiotrophin-1 protects the human myocardium from ischemic injury. Comparison with the first and second window of protection by ischemic preconditioning. Cardiovasc Res (2000) 0.86
Influence of prenatal alcohol exposure on myocardial contractile function in adult rat hearts: role of intracellular calcium and apoptosis. Alcohol Alcohol (2002) 0.85
Cardioprotection by Carvedilol: antiapoptosis is independent of beta-adrenoceptor blockage in the rat heart. J Cardiovasc Pharmacol Ther (2003) 0.83
Chronic treatment with carvedilol improves ventricular function and reduces myocyte apoptosis in an animal model of heart failure. BMC Physiol (2003) 0.83
Effects of epinephrine and phosphodiesterase III inhibitors on bupivacaine-induced myocardial depression in guinea-pig papillary muscle. Br J Anaesth (2003) 0.82
Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts. Circulation (2004) 0.81
Cardioprotective effects of vasopeptidase inhibition vs. angiotensin type 1-receptor blockade in spontaneously hypertensive rats on a high salt diet. Hypertens Res (2004) 0.81
Effects of pimobendan and EGIS 9377, cardiotonic agents, and OG-VI, a nucleoside-nucleotide mixture, administered during reperfusion after ischemia on stunned myocardium in dogs. Coron Artery Dis (2000) 0.80
Protection of the hypoxic myocardium by the bispyridine derivatives AWD 122-14 and milrinone: studies on isolated, working right rabbit hearts. Pharmazie (1992) 0.78
Effects of conventional hypothermic ischemic arrest and pharmacological arrest on myocardial supply/demand balance during aortic cross-clamping. Ann Thorac Surg (1977) 0.78
Carvedilol: a nonselective beta blocking agent with antioxidant properties. Congest Heart Fail (2002) 0.77
Association of pulmonary conduit type and size with durability in infants and young children. Ann Thorac Surg (2013) 2.06
Role of apoptosis in myocardial stunning after open heart surgery. Ann Thorac Surg (2002) 1.65
Prophylaxis of thromboembolic complications after the Fontan operation (total cavopulmonary anastomosis). J Thorac Cardiovasc Surg (2005) 1.64
Primary malignant sarcomas of the heart and great vessels in adult patients--a single-center experience. Oncologist (2007) 1.63
Pneumonectomy: calculable or non-tolerable risk factor in trimodal therapy for Stage III non-small-cell lung cancer? Eur J Cardiothorac Surg (2012) 1.53
Unsupported reduction ascending aortoplasty: fate of diameter and of Windkessel function. Ann Thorac Surg (2007) 1.43
[A case of acute and intense thoracic pain during a dental treatment]. Dtsch Med Wochenschr (2010) 1.40
Cerebral protection during surgery for acute aortic dissection type A: results of the German Registry for Acute Aortic Dissection Type A (GERAADA). Circulation (2011) 1.40
A practical approach for bridging anticoagulation after mechanical heart valve replacement. J Heart Valve Dis (2008) 1.39
A new technique for the isolation and surface immobilization of mesenchymal stem cells from whole bone marrow using high-specific DNA aptamers. Stem Cells (2006) 1.29
Sirolimus-eluting stents for the treatment of obstructive superficial femoral artery disease: six-month results. Circulation (2002) 1.27
Autograft reinforcement to preserve autograft function after the ross procedure: a report from the german-dutch ross registry. Circulation (2009) 1.23
Aptamer-based capture molecules as a novel coating strategy to promote cell adhesion. J Cell Mol Med (2005) 1.18
Oral anticoagulant treatment: friend or foe in cardiovascular disease? Blood (2004) 1.17
CELL-SELEX: Novel perspectives of aptamer-based therapeutics. Int J Mol Sci (2008) 1.17
Effects of intravenous glucagon-like peptide-1 on glucose control and hemodynamics after coronary artery bypass surgery in patients with type 2 diabetes. Am J Cardiol (2008) 1.13
Results of surgery for Ebstein anomaly: a multicenter study from the European Congenital Heart Surgeons Association. J Thorac Cardiovasc Surg (2006) 1.07
Platelets recruit human dendritic cells via Mac-1/JAM-C interaction and modulate dendritic cell function in vitro. Arterioscler Thromb Vasc Biol (2007) 1.07
DDD pacemaker implantation after Fontan-type operations. Pacing Clin Electrophysiol (2003) 1.06
The improvement of care for paediatric and congenital cardiac disease across the World: a challenge for the World Society for Pediatric and Congenital Heart Surgery. Cardiol Young (2008) 1.04
Upgrading SELEX technology by using lambda exonuclease digestion for single-stranded DNA generation. Molecules (2009) 1.02
Ultrasound estimation of volume of postoperative pleural effusion in cardiac surgery patients. Interact Cardiovasc Thorac Surg (2009) 1.02
Effect of biopassive and bioactive surface-coatings on the hemocompatibility of membrane oxygenators. J Biomed Mater Res B Appl Biomater (2007) 1.00
Surgery on extracorporeal circulation in early and advanced non-small cell lung cancer. Thorac Cardiovasc Surg (2012) 0.99
Hemocompatibility of heparin-coated surfaces and the role of selective plasma protein adsorption. Biomaterials (2002) 0.97
Fontan-type procedures: residual lesions and late interventions. Ann Thorac Surg (2002) 0.95
Surgery on unfavourable persistent N2/N3 non-small-cell lung cancer after trimodal therapy: do the results justify the risk? Interact Cardiovasc Thorac Surg (2012) 0.95
Immobilized DNA aptamers used as potent attractors for porcine endothelial precursor cells. J Biomed Mater Res A (2008) 0.94
Streptavidin-coated magnetic beads for DNA strand separation implicate a multitude of problems during cell-SELEX. Oligonucleotides (2009) 0.93
Pathomorphologic evaluation of pulmonary radiofrequency ablation: proof of cell death is characterized by DNA fragmentation and apoptotic bodies. Cancer (2008) 0.91
Risk of surgery for congenital heart disease in the adult: a multicentered European study. Ann Thorac Surg (2007) 0.91
A novel in vitro model for preclinical testing of the hemocompatibility of intravascular stents according to ISO 10993-4. J Mater Sci Mater Med (2011) 0.90
The arterial switch operation in Europe for transposition of the great arteries: a multi-institutional study from the European Congenital Heart Surgeons Association. J Thorac Cardiovasc Surg (2006) 0.90
New strategies for in vivo tissue engineering by mimicry of homing factors for self-endothelialisation of blood contacting materials. Biomaterials (2008) 0.89
Suppression of ICAM-1 in human venous endothelial cells by small interfering RNAs. Eur J Cardiothorac Surg (2005) 0.88
Anomalous origin of left coronary artery in young athletes with syncope. BMJ (2006) 0.88
Platelet aggregation monitoring with a newly developed quartz crystal microbalance system as an alternative to optical platelet aggregometry. Analyst (2010) 0.88
Blood cell and plasma protein repellent properties of star-PEG-modified surfaces. J Biomater Sci Polym Ed (2006) 0.88
Induction of EPC homing on biofunctionalized vascular grafts for rapid in vivo self-endothelialization--a review of current strategies. Biotechnol Adv (2009) 0.88
Endothelial progenitor cell capture stents--hype or hope? Int J Cardiol (2009) 0.87
Platelet anaesthesia during extracorporeal circulation: differential effects of GP IIb/IIIa blockers on platelet activation marker P-selectin expression at hypothermia. Thromb Res (2008) 0.87
Treatment of periprosthetic soft tissue infection of the groin following vascular surgical procedures by means of a polyvinyl alcohol-vacuum sponge system. Wound Repair Regen (2003) 0.87
Hemocompatibility of PMEA coated oxygenators used for extracorporeal circulation procedures. ASAIO J (2004) 0.87
Analysis of tumor antigen-specific T cells and antibodies in cancer patients treated with radiofrequency ablation. Int J Cancer (2010) 0.86
Thoracic spondylitis from a mycotic (Streptococcus pneumoniae) aortic aneurysm: a case report. Spine (Phila Pa 1976) (2004) 0.86
Major adverse cardiac and cerebrovascular events after the Ross procedure: a report from the German-Dutch Ross Registry. Circulation (2010) 0.86
Who gains most? A 10-year experience with 611 thoracoscopic talc pleurodeses. Ann Thorac Surg (2007) 0.85
Identification of HLA ligands and T-cell epitopes for immunotherapy of lung cancer. Cancer Immunol Immunother (2013) 0.85
Restrictive ventricular septal defect and critical subaortic stenosis in tetralogy of Fallot. Clin Res Cardiol (2010) 0.85
Critical temperature ranges of hypothermia-induced platelet activation: possible implications for cooling patients in cardiac surgery. Thromb Haemost (2007) 0.85
Solitary pulmonary nodules: association between signal characteristics in dynamic contrast enhanced MRI and tumor angiogenesis. Lung Cancer (2006) 0.85
Autograft regurgitation and aortic root dimensions after the Ross procedure: the German Ross Registry experience. Circulation (2007) 0.84
Pitfalls of cell-systematic evolution of ligands by exponential enrichment (SELEX): existing dead cells during in vitro selection anticipate the enrichment of specific aptamers. Oligonucleotides (2010) 0.84
Use of the implantable loop recorder in children and adolescents. Cardiol Young (2006) 0.84
Selective inhibition of the platelet phosphoinositide 3-kinase p110beta as promising new strategy for platelet protection during extracorporeal circulation. Thromb Haemost (2008) 0.83
Forty years of clinical aprotinin use: a review of 124 hypersensitivity reactions. Ann Thorac Surg (2005) 0.83
Inhibition of adhesion molecule expression on human venous endothelial cells by non-viral siRNA transfection. J Cell Mol Med (2007) 0.83
Graft protection in bypass surgery: siRNA-mediated silencing of adhesion molecules. Oligonucleotides (2009) 0.81
Occlusion versus shunting during MIDCAB: effects on left ventricular function and quality of anastomosis. Ann Thorac Surg (2002) 0.81
The nonselective beta-blocker carvedilol suppresses apoptosis in human cardiac tissue: a pilot study. Heart Surg Forum (2010) 0.81
CD41 Western blotting: a new method to detect platelet adhesion to artificial surfaces used in extracorporeal circulation procedures. J Mater Sci Mater Med (2008) 0.81
Aptamer-based strategies for stem cell research. Mini Rev Med Chem (2007) 0.81
Small-interfering RNA-eluting surfaces as a novel concept for intravascular local gene silencing. Mol Med (2011) 0.80
Peripheral arteries: treatment with antibodies of platelet receptors and reteplase for thrombolysis--APART trial. Radiology (2006) 0.80
The challenge to verify ceramide's role of apoptosis induction in human cardiomyocytes--a pilot study. J Cardiothorac Surg (2011) 0.80
Elevated serum levels of heat shock protein 70 can be detected after radiofrequency ablation. Cell Stress Chaperones (2011) 0.80
Neuroprotective effects of erythropoietin during deep hypothermic circulatory arrest. Eur J Cardiothorac Surg (2009) 0.80
Optimized basic conditions are essential for successful siRNA transfection into primary endothelial cells. Oligonucleotides (2009) 0.80
Thrombolysis to treat thrombi of the aortic arch. Clin Appl Thromb Hemost (2010) 0.80
Sarcoma of follicular dendritic cells in the dorsal mediastinum. Hum Pathol (2004) 0.80
Anaphylactic reaction after systemic application of aprotinin triggered by aprotinin-containing fibrin sealant. Anesth Analg (2008) 0.80
Does dose matter? Effect of two different neoadjuvant protocols in advanced NSCLC. Thorac Cardiovasc Surg (2012) 0.79
Aptamers influence the hemostatic system by activating the intrinsic coagulation pathway in an in vitro Chandler-Loop model. Clin Appl Thromb Hemost (2008) 0.79
The effect of electrochemical functionalization of Ti-alloy surfaces by aptamer-based capture molecules on cell adhesion. Biomaterials (2006) 0.79
Transvenous removal of an entangled central venous line following complex cardiac surgery. Pacing Clin Electrophysiol (2009) 0.79
NCO-sP(EO-stat-PO) coatings on gold sensors--a QCM study of hemocompatibility. Sensors (Basel) (2011) 0.79
Using reagent-supported thromboelastometry (ROTEM) to monitor haemostatic changes in congenital heart surgery employing deep hypothermic circulatory arrest. Eur J Cardiothorac Surg (2008) 0.79
Glycoprotein IIb/IIIa inhibition reduces prothrombotic events under conditions of deep hypothermic circulatory arrest. Thromb Haemost (2005) 0.79
PVC-plasticizer DEHP in medical products: do thin coatings really reduce DEHP leaching into blood? Perfusion (2005) 0.78
Comparison of late results of arterial switch versus atrial switch (mustard procedure) operation for transposition of the great arteries. Am J Cardiol (2013) 0.78
Local control in Ewing sarcoma of the chest wall: results of the EURO-EWING 99 trial. Ann Surg Oncol (2015) 0.78
Delayed development of pneumothorax after pulmonary radiofrequency ablation. Cardiovasc Intervent Radiol (2009) 0.78
Porcine EPCs downregulate stem cell markers and upregulate endothelial maturation markers during in vitro cultivation. J Tissue Eng Regen Med (2009) 0.78
The GP IIb/IIIa inhibitor abciximab (ReoPro) decreases activation and interaction of platelets and leukocytes during in vitro cardiopulmonary bypass simulation. Eur J Cardiothorac Surg (2005) 0.78
Sodium-hydrogen inhibitor cariporide (HOE 642) improves in situ protection of hearts from non-heart-beating donors. J Heart Lung Transplant (2003) 0.78
Gene expression changes in leukocytes during cardiopulmonary bypass are dependent on circuit coating. Circulation (2005) 0.78
Thrombospondin 1 as possible key factor in the hemocompatibility of endocoronary prostheses. Biomaterials (2005) 0.78
Usefulness of BNP-administration in cardiac surgery: animal model. Scand Cardiovasc J (2007) 0.77
The challenge to detect heart transplant rejection and transplant vasculopathy non-invasively - a pilot study. J Cardiothorac Surg (2009) 0.77